Cardiac sympathetic innervation assessed with 123 I-MIBG retains prognostic utility in diabetic patients with severe left ventricular dysfunction evaluated for primary prevention implantable cardioverter-defibrillator

2016 ◽  
Vol 35 (2) ◽  
pp. 74-80
Author(s):  
P. García-González ◽  
Ó. Fabregat-Andrés ◽  
P. Cozar-Santiago ◽  
R. Sánchez-Jurado ◽  
J. Estornell-Erill ◽  
...  
Keyword(s):  
Primary Prevention ◽  
Implantable Cardioverter Defibrillator ◽  
Ventricular Dysfunction ◽  
Sympathetic Innervation ◽  
Left Ventricular ◽  
Diabetic Patients ◽  
Severe Left Ventricular Dysfunction ◽  
Cardiac Sympathetic Innervation ◽  
Cardioverter Defibrillator ◽  
Prognostic Utility

Cardiac Sympathetic Innervation and Appropriate Therapies in Patients With an Implantable Cardioverter-defibrillator in Primary Prevention

2019 ◽  
Vol 72 (2) ◽  
pp. 180-182
Author(s):  
Marina Navarro-Peñalver ◽  
Laroussi Mohamed-Salem ◽  
Fernando Domínguez ◽  
F. Javier de Haro-Del Moral ◽  
Ignacio Fernández-Lozano ◽  
...  
Keyword(s):  
Primary Prevention ◽  
Implantable Cardioverter Defibrillator ◽  
Sympathetic Innervation ◽  
Cardiac Sympathetic Innervation ◽  
Cardioverter Defibrillator
Sign in / Sign up

Export Citation Format

Share Document